Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Leading National TMS provider—more locations, more doctors, more experience, more success!
Jan 17
A few months ago, even a trip to the park with her little boy would’ve been a chore for 37-year-old Lelah Harwood, because of depression.
“It’s affected everything,” Harwood said. “Relationships, jobs — every part of my life.”
Insurance coverage is widely available
Insurance Coverage Information
Patient Self Assessment & Tools
TMS Information for Practitioners
APA Guidelines
TMS Success Stories
NEWS / RESEARCH
